Skip to main content

Together we are beating cancer

Donate now

Health & Medicine

Find out more about the latest cancer treatments, clinical trials, cancer prevention and health policy
Showing 12 out of 650 results
Section of human colon showing sausage-shaped crypts.

Seven years after roll out began in England, bowel scope was still not being offered to everyone. And today, the test was removed from the roster. Seven years after roll out began in England, bowel scope was still not being offered to everyone. And today, the test was removed from the roster.

by Rachael Ogley | Analysis | 14 January 2021

14 January 2021

Cancer Research UK logo

Young people are being exposed to junk food adverts across social media, streaming services and by celebrities and influencers Young people are being exposed to junk food adverts across social media, streaming services and by celebrities and influencers

by Cancer Research UK | News | 18 December 2020

18 December 2020

Senedd in Wales.

Confusion over the symptoms of lung cancer and COVID-19 may be responsible for a drop in the number of people being referred for lung cancer tests in Wales. Confusion over the symptoms of lung cancer and COVID-19 may be responsible for a drop in the number of people being referred for lung cancer tests in Wales.

by Cancer Research UK | News | 20 November 2020

20 November 2020

Lung cancer cells under a microscope

The Scottish Medicines Consortium (SMC) has approved 4 new cancer drugs for use on the NHS in Scotland to treat some lung, breast and prostate cancers. The Scottish Medicines Consortium (SMC) has approved 4 new cancer drugs for use on the NHS in Scotland to treat some lung, breast and prostate cancers.

by Cancer Research UK | News | 13 November 2020

13 November 2020

An illustration of T cells (white) attacking a tumour (purple)

Some people with head and neck cancer will now have access to the immunotherapy drug pembrolizumab (Keytruda) on the NHS in England.    Some people with head and neck cancer will now have access to the immunotherapy drug pembrolizumab (Keytruda) on the NHS in England.   

by Cancer Research UK | News | 26 October 2020

26 October 2020